Figure 3

Measurement of GEC in patients with HIV-infection: A. Galactose elimination capacity - determined before and 6 months after initiation of ART - was not influenced by various anti-retroviral regimens. B. GEC was not significantly reduced during co-infection with hepatitis C virus. C. The metabolic liver capacity oscillated under long-term therapy for 3 to 6 months remained unchanged without obvious tendency. PAT = patients' number; GEKDIF = differences in GEC.